For: | Ganepola GA, Nizin J, Rutledge JR, Chang DH. Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer. World J Gastrointest Oncol 2014; 6(4): 83-97 [PMID: 24734154 DOI: 10.4251/wjgo.v6.i4.83] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v6/i4/83.htm |
Number | Citing Articles |
1 |
Ihsan Ullah, Le Yang, Feng-Ting Yin, Ye Sun, Xing-Hua Li, Jing Li, Xi-Jun Wang. Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives. Cancers 2022; 14(22): 5545 doi: 10.3390/cancers14225545
|
2 |
Somayeh Igder, Mozhdeh Zamani, Shima Fakher, Morvarid Siri, Hassan Ashktorab, Negar Azarpira, Pooneh Mokarram, Sowjanya Thatikonda. Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value. Disease Markers 2024; 2024: 1 doi: 10.1155/2024/9943412
|
3 |
Laura Ciarloni, Sahar Hosseinian Ehrensberger, Natsuko Imaizumi, Sylvain Monnier-Benoit, Cristina Nichita, Seung-Jae Myung, Joo Sung Kim, Si Young Song, Tae Il Kim, Boudewijn van der Weg, Rémy Meier, Jan Borovicka, Christoph Beglinger, Cédric Vallet, Philippe Maerten, Curzio Rüegg, Gian Dorta. Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer. Clinical Cancer Research 2016; 22(18): 4604 doi: 10.1158/1078-0432.CCR-15-2057
|
4 |
Tek Nath Yogi, Amrit Bhusal, Soniya Dulal, Rajeev Sharma, Krish Rauniyar. Pioneering colorectal cancer screening: blood-based DNA tests as a global strategy for early detection – editorial. International Journal of Surgery 2024; 110(11): 6906 doi: 10.1097/JS9.0000000000001964
|
5 |
Meifang Tang, Liuhong Zeng, Zhaolei Zeng, Jie Liu, Jie Yuan, Dongjie Wu, Ying Lu, Jin Zi, Mingzhi Ye. Proteomics study of colorectal cancer and adenomatous polyps identifies TFR1, SAHH, and HV307 as potential biomarkers for screening. Journal of Proteomics 2021; 243: 104246 doi: 10.1016/j.jprot.2021.104246
|
6 |
Chenghua Zhang, Ran Xia, Bo Zhang, Haibo Wang. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-5017-y
|
7 |
Maria Teresa Rodia, Giampaolo Ugolini, Gabriella Mattei, Isacco Montroni, Davide Zattoni, Federico Ghignone, Giacomo Veronese, Giorgia Marisi, Mattia Lauriola, Pierluigi Strippoli, Rossella Solmi. Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection. Oncotarget 2016; 7(21): 30295 doi: 10.18632/oncotarget.8108
|
8 |
Shangyuan Feng, Wenbo Wang, Isabella T. Tai, Guannan Chen, Rong Chen, Haishan Zeng. Label-free surface-enhanced Raman spectroscopy for detection of colorectal cancer and precursor lesions using blood plasma. Biomedical Optics Express 2015; 6(9): 3494 doi: 10.1364/BOE.6.003494
|
9 |
Divya B. Bhatt, Valerie-Sue Emuakhagbon. Current Trends in Colorectal Cancer Screening. Current Colorectal Cancer Reports 2019; 15(2): 45 doi: 10.1007/s11888-019-00432-4
|
10 |
An-Jun Wang, Dingka Song, Yue-Mei Hong, Ning-Ning Liu. Multi-omics insights into the interplay between gut microbiota and colorectal cancer in the “microworld” age. Molecular Omics 2023; 19(4): 283 doi: 10.1039/D2MO00288D
|
11 |
Łukasz Pietrzyk. Biomarkers Discovery for Colorectal Cancer: A Review on Tumor Endothelial Markers as Perspective Candidates. Disease Markers 2016; 2016: 1 doi: 10.1155/2016/4912405
|
12 |
M. C. J. van Lanschot, L. J. W. Bosch, M. de Wit, B. Carvalho, G. A. Meijer. Early detection: the impact of genomics. Virchows Archiv 2017; 471(2): 165 doi: 10.1007/s00428-017-2159-2
|
13 |
John E Blume, Michael Wilhelmsen, Ryan W Benz, Nils Brünner, Ib J Christensen, Lisa J Croner, Roslyn Dillon, Thore Hillig, Jeffrey J Jones, Lars N Jørgensen, Athit Kao, Michael Klaerke, Søren Laurberg, Mogens R Madsen, Knud T Nielsen, Jesper Vilandt, Bruce E Wilcox, Jia You, Hans J Nielsen. Discovery and Validation of Plasma-Protein Biomarker Panels for the Detection of Colorectal Cancer and Advanced Adenoma in a Danish Collection of Samples from Patients Referred for Diagnostic Colonoscopy. The Journal of Applied Laboratory Medicine 2016; 1(2): 181 doi: 10.1373/jalm.2016.020271
|
14 |
|
15 |
Hironori Kumagai, Kosuke Yamada, Kanako Nakai, Tokio Kitamura, Kohta Mohri, Masami Ukawa, Takumi Tomono, Takaaki Eguchi, Testuya Yoshizaki, Takumi Fukuchi, Takuya Yoshino, Minoru Matsuura, Etsuo Tobita, Wellington Pham, Hiroshi Nakase, Shinji Sakuma. Tumor recognition of peanut agglutinin-immobilized fluorescent nanospheres in biopsied human tissues. European Journal of Pharmaceutics and Biopharmaceutics 2019; 136: 29 doi: 10.1016/j.ejpb.2019.01.007
|
16 |
Łukasz Pietrzyk, Paulina Wdowiak. Endosialin (TEM1) as a Diagnostic, Progression, and Prognostic Serum Marker for Patients With Colorectal Cancer—A Preliminary Study. Cancer Control 2020; 27(1) doi: 10.1177/1073274820903351
|
17 |
Loretta De Chiara, María Gallardo-Gómez, Vicent Hernández, Oscar J. Cordero. Foundations of Colorectal Cancer. 2022; : 45 doi: 10.1016/B978-0-323-90055-3.00055-7
|
18 |
Paul D Wagner. Biomarkers in Cancer Screening and Early Detection. 2017; : 141 doi: 10.1002/9781118468869.ch12
|
19 |
Gongping Sun, Jin Meng, He Duan, Dewei Zhang, Yuanxin Tang. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis. Pathology & Oncology Research 2019; 25(4): 1525 doi: 10.1007/s12253-018-0559-5
|
20 |
Enea Ferlizza, Rossella Solmi, Rossella Miglio, Elena Nardi, Gabriella Mattei, Michela Sgarzi, Mattia Lauriola. Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects. Journal of Advanced Research 2020; 24: 99 doi: 10.1016/j.jare.2020.03.001
|
21 |
Enea Ferlizza, Rossella Solmi, Michela Sgarzi, Luigi Ricciardiello, Mattia Lauriola. The Roadmap of Colorectal Cancer Screening. Cancers 2021; 13(5): 1101 doi: 10.3390/cancers13051101
|
22 |
Konstantinos Panagiotopoulos, Aigli Korfiati, Konstantinos Theofilatos, Peter Hurwitz, Marco Agostino Deriu, Seferina Mavroudi, Jonathan Wren. MEvA-X: a hybrid multiobjective evolutionary tool using an XGBoost classifier for biomarkers discovery on biomedical datasets. Bioinformatics 2023; 39(7) doi: 10.1093/bioinformatics/btad384
|
23 |
Ming-Yii Huang, Hsueh-Chiao Liu, Li-Chen Yen, Jia-Yuan Chang, Jian-Jhang Huang, Jaw-Yuan Wang, Chao-Peng Hsiao, Shiu-Ru Lin. Detection of activated KRAS from cancer patient peripheral blood using a weighted enzymatic chip array. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/1479-5876-12-147
|
24 |
Brandi N. Snyder‐Talkington, Chunlin Dong, Linda M. Sargent, Dale W. Porter, Lauren M. Staska, Ann F. Hubbs, Rebecca Raese, Walter McKinney, Bean T. Chen, Lori Battelli, David T. Lowry, Steven H. Reynolds, Vincent Castranova, Yong Qian, Nancy L. Guo. mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo‐alveolar adenoma and adenocarcinoma after multi‐walled carbon nanotube inhalation exposure in mice. Journal of Applied Toxicology 2016; 36(1): 161 doi: 10.1002/jat.3157
|
25 |
Elena Ionica, Gisela Gaina, Mihaela Tica, Mariana-Carmen Chifiriuc, Gratiela Gradisteanu-Pircalabioru. Contribution of Epithelial and Gut Microbiome Inflammatory Biomarkers to the Improvement of Colorectal Cancer Patients’ Stratification. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.811486
|
26 |
Pedro Nascimento de Lima, Rosita van den Puttelaar, Amy B Knudsen, Anne I Hahn, Karen M Kuntz, Jonathan Ozik, Nicholson Collier, Fernando Alarid-Escudero, Ann G Zauber, John M Inadomi, Iris Lansdorp-Vogelaar, Carolyn M Rutter. Characteristics of a cost-effective blood test for colorectal cancer screening. JNCI: Journal of the National Cancer Institute 2024; 116(10): 1612 doi: 10.1093/jnci/djae124
|
27 |
Isabelle Souza Luz, Raquel Takaya, Daiane Gonzaga Ribeiro, Mariana S. Castro, Wagner Fontes. Mass Spectrometry-Based Approaches for Treating Human Diseases and Diagnostics. Advances in Experimental Medicine and Biology 2024; 1443: 221 doi: 10.1007/978-3-031-50624-6_12
|
28 |
Ondrej Slaby. Non-coding RNAs in Colorectal Cancer. Advances in Experimental Medicine and Biology 2016; 937: 153 doi: 10.1007/978-3-319-42059-2_8
|
29 |
Monica Benvenuto, Pierpaolo Sileri, Piero Rossi, Laura Masuelli, Massimo Fantini, Monica Nanni, Luana Franceschilli, Giuseppe Sconocchia, Giulia Lanzilli, Roberto Arriga, Giovanni Faggioni, Florigio Lista, Augusto Orlandi, Vittorio Manzari, Achille Lucio Gaspari, Andrea Modesti, Roberto Bei. Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0455-7
|
30 |
Kunitoshi Shigeyasu, Shusuke Toden, Timothy J. Zumwalt, Yoshinaga Okugawa, Ajay Goel. Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers. Clinical Cancer Research 2017; 23(10): 2391 doi: 10.1158/1078-0432.CCR-16-1676
|
31 |
Samina Ejaz, Faiz-ul-Hassan Nasim, Muhammad Ashraf, Gulzar Ahmad. Down-regulation of hK7 in the sera of breast cancer and benign breast disease patients. Heliyon 2017; 3(7): e00356 doi: 10.1016/j.heliyon.2017.e00356
|
32 |
Xia Gan, Ting Wang, Zhi-Yong Chen, Kun-He Zhang. Blood-derived molecular signatures as biomarker panels for the early detection of colorectal cancer. Molecular Biology Reports 2020; 47(10): 8159 doi: 10.1007/s11033-020-05838-0
|
33 |
Megha Bhardwaj, Tobias Terzer, Petra Schrotz-King, Hermann Brenner. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer. International Journal of Molecular Sciences 2021; 22(3): 1189 doi: 10.3390/ijms22031189
|
34 |
Michael Wilhelmsen, Ib J. Christensen, Louise Rasmussen, Lars N. Jørgensen, Mogens R. Madsen, Jesper Vilandt, Thore Hillig, Michael Klaerke, Knud T. Nielsen, Søren Laurberg, Nils Brünner, Susan Gawel, Xiaoqing Yang, Gerard Davis, Annemieke Heijboer, Frans Martens, Hans J. Nielsen. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers. International Journal of Cancer 2017; 140(6): 1436 doi: 10.1002/ijc.30558
|
35 |
Hongjian Gao, Chunxia Zhang. miR-3133 is an unfavorable prognosis factor and tumor suppressor in colon cancer. Functional & Integrative Genomics 2023; 23(2) doi: 10.1007/s10142-023-01059-3
|
36 |
Nina Hauptman, Damjan Glavač. Colorectal Cancer Blood-Based Biomarkers. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/2195361
|
37 |
Łukasz Pietrzyk, Paulina Wdowiak. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients. Advances in Medical Sciences 2019; 64(2): 402 doi: 10.1016/j.advms.2019.07.001
|
38 |
Abdo Alnabulsi, Graeme I. Murray. Proteomics for early detection of colorectal cancer: recent updates. Expert Review of Proteomics 2018; 15(1): 55 doi: 10.1080/14789450.2018.1396893
|
39 |
Ozal Beylerli, Ilgiz Gareev, Albert Sufianov, Tatiana Ilyasova, Yang Guang. Long noncoding RNAs as promising biomarkers in cancer. Non-coding RNA Research 2022; 7(2): 66 doi: 10.1016/j.ncrna.2022.02.004
|
40 |
Ming-Yii Huang, Hsueh-Chiao Liu, Li-Chen Yen, Jia-Yuan Chang, Jian-Jhang Huang, Jaw-Yuan Wang, Shiu-Ru Lin. Decreasing relapse in colorectal cancer patients treated with cetuximab by using the activating KRAS detection chip. Tumor Biology 2014; 35(10): 9639 doi: 10.1007/s13277-014-2263-8
|
41 |
Ebru E. Yörüker, Stefan Holdenrieder, Ugur Gezer. Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer. Clinica Chimica Acta 2016; 455: 26 doi: 10.1016/j.cca.2016.01.016
|
42 |
Junfei Zhang, Yuanxin Du, Yongcai Zhang, Yanan Xu, Yanying Fan, Yan Li. 1H-NMR Based Metabolomics Technology Identifies Potential Serum Biomarkers of Colorectal Cancer Lung Metastasis in a Mouse Model. Cancer Management and Research 2022; : 1457 doi: 10.2147/CMAR.S348981
|
43 |
Cigdem Gungormez, Hatice Gumushan Aktas, Nihat Dilsiz, Ersin Borazan. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis. Molecular Biology Reports 2019; 46(4): 4175 doi: 10.1007/s11033-019-04868-7
|
44 |
Wenxian Zhang, Guangchun Xiao, Jun Chen, Li Wang, Qiongzheng Hu, Jian Wu, Wenhong Zhang, Ming Song, Jinwei Qiao, Chonghai Xu. Electrochemical biosensors for measurement of colorectal cancer biomarkers. Analytical and Bioanalytical Chemistry 2021; 413(9): 2407 doi: 10.1007/s00216-021-03197-8
|
45 |
Wen-Yue Song, Xin Zhang, Qi Zhang, Peng-Jun Zhang, Rong Zhang. Clinical value evaluation of serum markers for early diagnosis of colorectal cancer. World Journal of Gastrointestinal Oncology 2020; 12(2): 219-227 doi: 10.4251/wjgo.v12.i2.219
|
46 |
Vardit Moshayoff, Ouriel Faktor, Luigi Laghi, Giuseppe Celesti, Tamar Peretz, Dan Keret, Dana Cohen, Eran Israeli, Hiromu Suzuki. Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle. PLOS ONE 2016; 11(7): e0159522 doi: 10.1371/journal.pone.0159522
|
47 |
M. Alexander, J. B. Burch, S. E. Steck, C.-F. Chen, T. G. Hurley, P. Cavicchia, N. Shivappa, J. Guess, H. Zhang, S. D. Youngstedt, K. E. Creek, S. Lloyd, K. Jones, J. R. Hébert. Case-control study of candidate gene methylation and adenomatous polyp formation. International Journal of Colorectal Disease 2017; 32(2): 183 doi: 10.1007/s00384-016-2688-1
|
48 |
Satoshi Watabe, Hiromi Kodama, Mugiho Kaneda, Mika Morikawa, Kazunari Nakaishi, Teruki Yoshimura, Atsushi Iwai, Toshiaki Miura, Etsuro Ito. Ultrasensitive enzyme-linked immunosorbent assay (ELISA) of proteins by combination with the thio-NAD cycling method. BIOPHYSICS 2014; 10(0): 49 doi: 10.2142/biophysics.10.49
|
49 |
Manish Chand, Deborah S Keller, Reza Mirnezami, Marc Bullock, Aneel Bhangu, Brendan Moran, Paris P Tekkis, Gina Brown, Alexander Mirnezami, Mariana Berho. Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data. World Journal of Gastrointestinal Oncology 2018; 10(7): 145-158 doi: 10.4251/wjgo.v10.i7.145
|
50 |
Ofer Levi, Assaf Shapira, Baruch Tal, Itai Benhar, Noam Eliaz. Isolating EGFR Overexpressing Carcinoma Cells from Human Whole Blood by Bio-Ferrography. Cytometry Part B: Clinical Cytometry 2014; : n/a doi: 10.1002/cytob.21212
|
51 |
Fan Wang, Jeremy T.-H. Chang, Chester Jingshiu Kao, R. Stephanie Huang. High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro
. Molecular Cancer Therapeutics 2016; 15(5): 1123 doi: 10.1158/1535-7163.MCT-15-0943
|
52 |
Vishal Das, Jatin Kalita, Mintu Pal. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges. Biomedicine & Pharmacotherapy 2017; 87: 8 doi: 10.1016/j.biopha.2016.12.064
|
53 |
Bruno Augusto Alves Martins, Gabriel Fonseca de Bulhões, Igor Norat Cavalcanti, Mickaella Michelson Martins, Paulo Gonçalves de Oliveira, Aline Maria Araújo Martins. Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01284
|
54 |
Jingjing Guo, Bin Wang, Weikai Hou, Kun Ma. Risk factors for elevated serum colorectal cancer markers in patients with type 2 diabetes mellitus. Open Life Sciences 2020; 15(1): 267 doi: 10.1515/biol-2020-0030
|
55 |
Nolwenn Dubois, Emmanuel Rio, Natacha Ripoche, Véronique Ferchaud-Roucher, Marie-Hélène Gaugler, Loic Campion, Michel Krempf, Christian Carrie, Marc Mahé, Xavier Mirabel, François Paris. Plasma ceramide, a real-time predictive marker of pulmonary and hepatic metastases response to stereotactic body radiation therapy combined with irinotecan. Radiotherapy and Oncology 2016; 119(2): 229 doi: 10.1016/j.radonc.2016.03.014
|
56 |
Shaymaa Abdelraheem Abdelhady, Heba Attya, Mohamed Abdo, Fadia M. Attia. Clinical significance of golgi protein‐73 as a diagnostic marker for Egyptian patients with colorectal cancer: Preliminary study. Cancer Reports 2021; 4(5) doi: 10.1002/cnr2.1379
|
57 |
Ya-nan Wang, Zhao-hua Chen, Wei-chang Chen. Novel circulating microRNAs expression profile in colon cancer: a pilot study. European Journal of Medical Research 2017; 22(1) doi: 10.1186/s40001-017-0294-5
|
58 |
Wafaa M. Elzefzafy, Soheir Abd Elrahman, Zakia abuzahab Mohmmed, Nesreen Atef. Diagnostic utility of serum dipeptidyl peptidase (DPP- IV) /CD26 as a serum marker in Egyptian patients with colorectal cancer. Journal of Immunoassay and Immunochemistry 2020; 41(4): 729 doi: 10.1080/15321819.2020.1744642
|
59 |
Noshad Peyravian, Pegah Larki, Ehsan Gharib, Ehsan Nazemalhosseini-Mojarad, Fakhrosadate Anaraki, Chris Young, James McClellan, Maziar Ashrafian Bonab, Hamid Asadzadeh-Aghdaei, Mohammad Zali. The Application of Gene Expression Profiling in Predictions of Occult Lymph Node Metastasis in Colorectal Cancer Patients. Biomedicines 2018; 6(1): 27 doi: 10.3390/biomedicines6010027
|